{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:47:11Z","timestamp":1791193631512,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"19-20","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Med Wochenschr"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s10354-008-0592-1","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T12:11:44Z","timestamp":1226319104000},"page":"542-548","source":"Crossref","is-referenced-by-count":100,"title":["Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases","Bedeutung des Galle-Toxizit\u00e4t Konzeptes f\u00fcr die Pathogenese und Therapie von cholestatischen Lebererkrankungen"],"prefix":"10.1007","volume":"158","author":[{"given":"Michael","family":"Trauner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Fickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Halilbasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"592_CR1","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1152\/physrev.00027.2002","volume":"83","author":"M Trauner","year":"2003","unstructured":"Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. Physiol Rev, 83: 633\u2013671, 2003","journal-title":"Physiol Rev"},{"key":"592_CR2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00424-006-0062-9","volume":"453","author":"RP Oude Elferink","year":"2007","unstructured":"Oude Elferink RP, Paulusma CC. Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein). Pflugers Arch, 453: 601\u2013610, 2007","journal-title":"Pflugers Arch"},{"key":"592_CR3","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/j.gastro.2005.08.052","volume":"130","author":"RP Oude Elferink","year":"2006","unstructured":"Oude Elferink RP, Paulusma CC, Groen AK. Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology, 130: 908\u2013925, 2006","journal-title":"Gastroenterology"},{"key":"592_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1055\/s-2006-960172","volume":"27","author":"M Trauner","year":"2007","unstructured":"Trauner M, Fickert P, Wagner M. MDR3 (ABCB4) defects: a paradigm for the genetics of adult cholestatic syndromes. Semin Liver Dis, 27: 77\u201398, 2007","journal-title":"Semin Liver Dis"},{"key":"592_CR5","first-page":"106","volume":"27","author":"AF Hofmann","year":"1995","unstructured":"Hofmann AF. Bile acids as drugs: principles, mechanisms of action and formulations. Ital J Gastroenterol, 27: 106\u2013113, 1995","journal-title":"Ital J Gastroenterol"},{"key":"592_CR6","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1001\/archinte.159.22.2647","volume":"159","author":"AF Hofmann","year":"1999","unstructured":"Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med, 159: 2647\u20132658, 1999","journal-title":"Arch Intern Med"},{"key":"592_CR7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0092-8674(93)90380-9","volume":"75","author":"JJ Smit","year":"1993","unstructured":"Smit JJ, Schinkel AH, Oude Elferink RP, Groen AK, Wagenaar E, van Deemter L, Mol CA, Ottenhoff R, van der Lugt NM, van Roon MA, et al. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Cell, 75: 451\u2013462, 1993","journal-title":"Cell"},{"key":"592_CR8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","volume":"127","author":"P Fickert","year":"2004","unstructured":"Fickert P, Fuchsbichler A, Wagner M, Zollner G, Kaser A, Tilg H, Krause R, Lammert F, Langner C, Zatloukal K, Marschall HU, Denk H, Trauner M. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology, 127: 261\u2013274, 2004","journal-title":"Gastroenterology"},{"key":"592_CR9","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","volume":"123","author":"P Fickert","year":"2002","unstructured":"Fickert P, Zollner G, Fuchsbichler A, Stumptner C, Weiglein AH, Lammert F, Marschall HU, Tsybrovskyy O, Zatloukal K, Denk H, Trauner M. Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles. Gastroenterology, 123: 1238\u20131251, 2002","journal-title":"Gastroenterology"},{"key":"592_CR10","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jhep.2005.06.025","volume":"43","author":"Y Popov","year":"2005","unstructured":"Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. Mdr2 (Abcb4)\u2212\/\u2212 mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol, 43: 1045\u20131054, 2005","journal-title":"J Hepatol"},{"key":"592_CR11","first-page":"1237","volume":"145","author":"TH Mauad","year":"1994","unstructured":"Mauad TH, van Nieuwkerk CM, Dingemans KP, Smit JJ, Schinkel AH, Notenboom RG, van den Bergh Weerman MA, Verkruisen RP, Groen AK, Oude Elferink RP, et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am J Pathol, 145: 1237\u20131245, 1994","journal-title":"Am J Pathol"},{"key":"592_CR12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","volume":"431","author":"E Pikarsky","year":"2004","unstructured":"Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S, Gutkovich-Pyest E, Urieli-Shoval S, Galun E, Ben-Neriah Y. NF-\u03baB functions as a tumour promoter in inflammation-associated cancer. Nature, 431: 461\u2013466, 2004","journal-title":"Nature"},{"key":"592_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/hep.20022","volume":"39","author":"F Lammert","year":"2004","unstructured":"Lammert F, Wang DQ, Hillebrandt S, Geier A, Fickert P, Trauner M, Matern S, Paigen B, Carey MC. Spontaneous cholecysto- and hepatolithiasis in Mdr2\u2212\/\u2212 mice: a model for low phospholipid-associated cholelithiasis. Hepatology, 39: 117\u2013128, 2004","journal-title":"Hepatology"},{"key":"592_CR14","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1541-7786.MCR-07-0172","volume":"5","author":"M Katzenellenbogen","year":"2007","unstructured":"Katzenellenbogen M, Mizrahi L, Pappo O, Klopstock N, Olam D, Jacob-Hirsch J, Amariglio N, Rechavi G, Domany E, Galun E, Goldenberg D. Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice. Mol Cancer Res, 5: 1159\u20131170, 2007","journal-title":"Mol Cancer Res"},{"key":"592_CR15","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","volume":"113","author":"S Sheth","year":"2003","unstructured":"Sheth S, Shea JC, Bishop MD, et al. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis. Hum Genet, 113: 286\u2013292, 2003","journal-title":"Hum Genet"},{"key":"592_CR16","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00452.2003","volume":"287","author":"PG Blanco","year":"2004","unstructured":"Blanco PG, Zaman MM, Junaidi O, et al. Induction of colitis in cftr\u2212\/\u2212 mice results in bile duct injury. Am J Physiol Gastrointest Liver Physiol, 287: G491\u2013G496, 2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"592_CR17","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jpeds.2007.03.062","volume":"151","author":"H Pall","year":"2007","unstructured":"Pall H, Zielenski J, Jonas MM, et al. Primary sclerosing cholangitis in childhood is associated with abnormalities in cystic fibrosis-mediated chloride channel function. J Pediatr, 151: 255\u2013259, 2007","journal-title":"J Pediatr"},{"key":"592_CR18","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/BF02282335","volume":"41","author":"JM McGill","year":"1996","unstructured":"McGill JM, Williams DM, Hunt CM. Survey of cystic fibrosis transmembrane conductance regulator genotypes in primary sclerosing cholangitis. Dig Dis Sci, 41: 540\u2013542, 1996","journal-title":"Dig Dis Sci"},{"key":"592_CR19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0168-8278(02)00161-7","volume":"37","author":"E Girodon","year":"2002","unstructured":"Girodon E, Sternberg D, Chazouilleres O, et al. Cystic fibrosis transmembrane conductance regulator (CFTR) gene defects in patients with primary sclerosing cholangitis. J Hepatol, 37: 192\u2013197, 2002","journal-title":"J Hepatol"},{"key":"592_CR20","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1572-0241.2005.41072.x","volume":"100","author":"JF Gallegos-Orozco","year":"2005","unstructured":"Gallegos-Orozco JF, C EY, Wang N, et al. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis. Am J Gastroenterol, 100: 874\u2013878, 2005","journal-title":"Am J Gastroenterol"},{"key":"592_CR21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","volume":"127","author":"KN Lazaridis","year":"2004","unstructured":"Lazaridis KN, Strazzabosco M, LaRusso NF. The cholangiopathies: disorders of biliary epithelia. Gastroenterology, 127: 1565\u20131577, 2004","journal-title":"Gastroenterology"},{"key":"592_CR22","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0002-9440(10)63234-8","volume":"164","author":"PR Durie","year":"2004","unstructured":"Durie PR, Kent G, Phillips MJ, Ackerley CA. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol, 164: 1481\u20131493, 2004","journal-title":"Am J Pathol"},{"key":"592_CR23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.mpg.0000189368.37535.42","volume":"42","author":"H Pall","year":"2006","unstructured":"Pall H, Zaman MM, Andersson C, Freedman SD. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator\u2212\/\u2212 mice. J Pediatr Gastroenterol Nutr, 42: 275\u2013281, 2006","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"592_CR24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jcp.20020","volume":"200","author":"M Ollero","year":"2004","unstructured":"Ollero M, Junaidi O, Zaman MM, Tzameli I, Ferrando AA, Andersson C, Blanco PG, Bialecki E, Freedman SD. Decreased expression of peroxisome proliferator activated receptor gamma in cftr\u2212\/\u2212 mice. J Cell Physiol, 200: 235\u2013244, 2004","journal-title":"J Cell Physiol"},{"key":"592_CR25","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2353\/ajpath.2007.061133","volume":"171","author":"P Fickert","year":"2007","unstructured":"Fickert P, St\u00f6ger U, Fuchsbichler A, Moustafa T, Marschall HU, Weiglein AH, Tsybrovskyy O, Jaeschke H, Zatloukal K, Denk H, Trauner M. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis. Am J Pathol, 171: 525\u2013536, 2007","journal-title":"Am J Pathol"},{"key":"592_CR26","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3748\/wjg.v11.i1.104","volume":"11","author":"ML Chang","year":"2005","unstructured":"Chang ML, Yeh CT, Chang PY, Chen JC. Comparison of murine cirrhosis models induced by hepatotoxin administration and common bile duct ligation. World J Gastroenterol, 11: 4167\u20134172, 2005","journal-title":"World J Gastroenterol"},{"key":"592_CR27","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2353\/ajpath.2006.050404","volume":"168","author":"P Fickert","year":"2006","unstructured":"Fickert P, Fuchsbichler A, Marschall HU, Wagner M, Zollner G, Krause R, Zatloukal K, Jaeschke H, Denk H, Trauner M. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. Am J Pathol, 168: 410\u2013422, 2006","journal-title":"Am J Pathol"},{"key":"592_CR28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1034\/j.1478-3231.2003.00856.x","volume":"23","author":"PL Jansen","year":"2003","unstructured":"Jansen PL, Sturm E. Genetic cholestasis, causes and consequences for hepatobiliary transport. Liver Int, 23: 315\u2013322, 2003","journal-title":"Liver Int"},{"key":"592_CR29","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhep.2005.03.017","volume":"43","author":"C Pauli-Magnus","year":"2005","unstructured":"Pauli-Magnus C, Stieger B, Meier Y, Kullak-Ublick GA, Meier PJ. Enterohepatic transport of bile salts and genetics of cholestasis. J Hepatol, 43: 342\u2013357, 2005","journal-title":"J Hepatol"},{"key":"592_CR30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1053\/gast.2001.23984","volume":"120","author":"E Jacquemin","year":"2001","unstructured":"Jacquemin E, De Vree JM, Cresteil D, Sokal EM, Sturm E, Dumont M, Scheffer GL, Paul M, Burdelski M, Bosma PJ, Bernard O, Hadchouel M, Elferink RP. The wide spectrum of multidrug resistance 3 deficiency: from neonatalcholestasis to cirrhosis of adulthood. Gastroenterology, 120: 1448\u20131458, 2001","journal-title":"Gastroenterology"},{"key":"592_CR31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jhep.2004.08.023","volume":"41","author":"E Geuken","year":"2004","unstructured":"Geuken E, Visser D, Kuipers F, Blokzijl H, Leuvenink HG, de Jong KP, Peeters PM, Jansen PL, Slooff MJ, Gouw AS, Porte RJ. Rapid increase of bile salt secretion is associated with bile duct injury after human liver transplantation. J Hepatol, 41: 1017\u20131025, 2004","journal-title":"J Hepatol"},{"key":"592_CR32","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/hep.21169","volume":"43","author":"H Hoekstra","year":"2006","unstructured":"Hoekstra H, Porte RJ, Tian Y, Jochum W, Stieger B, Moritz W, Slooff MJ, Graf R, Clavien PA. Bile salt toxicity aggravates cold ischemic injury of bile ducts after liver transplantation in Mdr2+\/\u2212 mice. Hepatology, 43: 1022\u20131031, 2006","journal-title":"Hepatology"},{"key":"592_CR33","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","volume":"39","author":"C Pauli-Magnus","year":"2004","unstructured":"Pauli-Magnus C, Kerb R, Fattinger K, Lang T, Anwald B, Kullak-Ublick GA, Beuers U, Meier PJ. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis. Hepatology, 39: 779\u2013791, 2004","journal-title":"Hepatology"},{"key":"592_CR34","first-page":"265A","volume":"46","author":"E Melum","year":"2007","unstructured":"Melum E, Boberg KM, Franke A, Bergquist A, Hampe J, Schreiber S, Lie BA, Schrumpf E, Karlsen TH. Variation in the MDR3 gene influences disease progression in PSC patients and disease susceptibility in epistatic interaction with a polymorphism in the OST-alpha gene. Hepatology, 46: 265A, 2007","journal-title":"Hepatology"},{"key":"592_CR35","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0016-5085(93)90735-U","volume":"105","author":"J Prieto","year":"1993","unstructured":"Prieto J, Qian C, Garcia N, Diez J, Medina JF. Abnormal expression of anion exchanger genes in primary biliary cirrhosis. Gastroenterology, 105: 572\u2013578, 1993","journal-title":"Gastroenterology"},{"key":"592_CR36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/hep.510250104","volume":"25","author":"JF Medina","year":"1997","unstructured":"Medina JF, Martinez A, Vazquez JJ, Prieto J. Decreased anion exchanger 2 immunoreactivity in the liver of patients with primary biliary cirrhosis. Hepatology, 25: 12\u201317, 1997","journal-title":"Hepatology"},{"key":"592_CR37","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0016-5085(99)70564-0","volume":"117","author":"J Prieto","year":"1999","unstructured":"Prieto J, Garcia N, Marti-Climent JM, Penuelas I, Richter JA, Medina JF. Assessment of biliary bicarbonate secretion in humans by positron emission tomography. Gastroenterology, 117: 167\u2013172, 1999","journal-title":"Gastroenterology"},{"key":"592_CR38","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/jhep.2002.33634","volume":"35","author":"S Melero","year":"2002","unstructured":"Melero S, Spirli C, Zsembery A, et al. Defective regulation of cholangiocyte Cl\u2212\/HCO3 (\u2212) and Na\u2212\/H\u2212 exchanger activities in primary biliary cirrhosis. Hepatology, 35: 1513\u20131521, 2002","journal-title":"Hepatology"},{"key":"592_CR39","first-page":"1422","volume":"146","author":"JJ Vazquez","year":"1995","unstructured":"Vazquez JJ, Vazquez M, Idoate MA, et al. Anion exchanger immunoreactivity in human salivary glands in health and Sjogren's syndrome. Am J Pathol, 146: 1422\u20131432, 1995","journal-title":"Am J Pathol"},{"key":"592_CR40","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0168-8278(03)00096-5","volume":"38","author":"G Zollner","year":"2003","unstructured":"Zollner G, Fickert P, Silbert D, et al. Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis. J Hepatol, 38: 717\u2013727, 2003","journal-title":"J Hepatol"},{"key":"592_CR41","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/gast.2001.25516","volume":"121","author":"C Spirli","year":"2001","unstructured":"Spirli C, Nathanson MH, Fiorotto R, et al. Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. Gastroenterology, 121: 156\u2013169, 2001","journal-title":"Gastroenterology"},{"key":"592_CR42","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","volume":"44","author":"NF LaRusso","year":"2006","unstructured":"LaRusso NF, Shneider BL, Black D, Gores GJ, James SP, Doo E, Hoofnagle JH. Primary sclerosing cholangitis: summary of a workshop. Hepatology, 44: 746\u2013764, 2006","journal-title":"Hepatology"},{"key":"592_CR43","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-2006-933563","volume":"26","author":"SN Cullen","year":"2006","unstructured":"Cullen SN, Chapman RW. The medical management of primary sclerosing cholangitis. Semin Liver Dis, 26: 52\u201361, 2006","journal-title":"Semin Liver Dis"},{"key":"592_CR44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","volume":"3","author":"U Beuers","year":"2006","unstructured":"Beuers U. Drug insight: mechanisms and sites of action of ursodeoxycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol, 3: 318\u2013328, 2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"592_CR45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1089-3261(03)00135-1","volume":"8","author":"G Paumgartner","year":"2004","unstructured":"Paumgartner G, Beuers U. Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis, 8: 67\u201381, 2004","journal-title":"Clin Liver Dis"},{"key":"592_CR46","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/0016-5085(86)90859-0","volume":"90","author":"YB Yoon","year":"1986","unstructured":"Yoon YB, Hagey LR, Hofmann AF, Gurantz D, Michelotti EL, Steinbach JH. Effect of side-chain shortening on the physiologic properties of bile acids: hepatic transport and effect on biliary secretion of 23-nor-ursodeoxycholate in rodents. Gastroenterology, 90: 837\u2013852, 1986","journal-title":"Gastroenterology"},{"key":"592_CR47","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/hep.20943","volume":"42","author":"AF Hofmann","year":"2005","unstructured":"Hofmann AF, Zakko SF, Lira M, Clerici C, Hagey LR, Lambert KK, Steinbach JH, Schteingart CD, Olinga P, Groothuis GM. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology, 42: 1391\u20131398, 2005","journal-title":"Hepatology"},{"key":"592_CR48","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","volume":"130","author":"P Fickert","year":"2006","unstructured":"Fickert P, Wagner M, Marschall HU, Fuchsbichler A, Zollner G, Tsybrovskyy O, Zatloukal K, Liu J, Waalkes MP, Cover C, Denk H, Hofmann AF, Jaeschke H, Trauner M. 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology, 130: 465\u2013481, 2006","journal-title":"Gastroenterology"},{"key":"592_CR49","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0016-5085(99)70356-2","volume":"117","author":"U Bolder","year":"1999","unstructured":"Bolder U, Trang NV, Hagey LR, Schteingart CD, Ton-Nu HT, Cerre C, Elferink RP, Hofmann AF. Sulindac is excreted into bile by a canalicular bile salt pump and undergoes acholehepatic circulation in rats. Gastroenterology, 117: 962\u2013971, 1999","journal-title":"Gastroenterology"},{"key":"592_CR50","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00042737-200212000-00014","volume":"14","author":"M Leuschner","year":"2002","unstructured":"Leuschner M, Holtmeier J, Ackermann H, Leuschner U. The influence of sulindac on patients with primary biliary cirrhosis that responds incompletely to ursodeoxycholic acid: a pilot study. Eur J Gastroenterol Hepatol, 14: 1369\u20131376, 2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"592_CR51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall HU, Wagner M, Trauner M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm, 3: 231\u2013251, 2006","journal-title":"Mol Pharm"},{"key":"592_CR52","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbamcr.2006.04.014","volume":"1773","author":"A Geier","year":"2007","unstructured":"Geier A, Wagner M, Dietrich CG, Trauner M. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim Biophys Acta, 1773: 283\u2013308, 2007","journal-title":"Biochim Biophys Acta"},{"key":"592_CR53","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/hep.20784","volume":"42","author":"M Wagner","year":"2005","unstructured":"Wagner M, Halilbasic E, Marschall HU, Zollner G, Fickert P, Langner C, Zatloukal K, Denk H, Trauner M. CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice. Hepatology, 42: 420\u2013430, 2005","journal-title":"Hepatology"},{"key":"592_CR54","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/hep.21741","volume":"46","author":"T Stojakovic","year":"2007","unstructured":"Stojakovic T, Putz-Bankuti C, Fauler G, Scharnagl H, Wagner M, Stadlbauer V, Gurakuqi G, Stauber RE, M\u00e4rz W, Trauner M. Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. Hepatology, 46: 776\u2013784, 2007","journal-title":"Hepatology"},{"issue":"5","key":"592_CR55","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1053\/j.gastro.2008.02.020","volume":"134","author":"JT Salas","year":"2008","unstructured":"Salas JT, Banales JM, Sarvide S, Recalde S, Ferrer A, Uriarte I, Oude Elferink RP, Prieto J, Medina JF. Ae2a,b-deficient mice develop antimitochondrial antibodies and other features resembling primary biliary cirrhosis. Gastroenterology, 134(5): 1482\u20131493, 2008","journal-title":"Gastroenterology"}],"container-title":["Wiener Medizinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-008-0592-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10354-008-0592-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10354-008-0592-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T16:03:47Z","timestamp":1559145827000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10354-008-0592-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":55,"journal-issue":{"issue":"19-20","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["592"],"URL":"https:\/\/doi.org\/10.1007\/s10354-008-0592-1","relation":{},"ISSN":["0043-5341","1563-258X"],"issn-type":[{"value":"0043-5341","type":"print"},{"value":"1563-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}